Xenon Pharmaceuticals Inc. (XENE) › EPS (Diluted)Xenon Pharmaceuticals Inc. (XENE) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2012: $-3.242013: $1.912014: $3.282015: $-1.102016: $-1.482017: $-1.722018: $-1.632020: $-0.812021: $-1.772022: $-2.062023: $-2.732024: $-3.012025: $-4.36$-4.362012EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-4.36-44.9%2024$-3.01-10.3%2023$-2.73-32.5%2022$-2.06-16.4%2021$-1.77-118.5%2020$-0.81—2018$-1.63+5.2%2017$-1.72-16.2%2016$-1.48-34.5%2015$-1.10-133.5%2014$3.28+71.7%2013$1.91+159.0%2012$-3.24—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share